Decrease of gene expression of astrocytic 5-HT2B receptors parallels development of depressive phenotype in a mouse model of Parkinson’s disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decrease of gene expression of astrocytic 5-HT2B receptors parallels development of depressive phenotype in a mouse model of Parkinson’s disease
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-10-06
DOI
10.3389/fncel.2015.00388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ammonium increases Ca2+signalling and upregulates expression of Cav1.2 gene in astrocytes in primary cultures and in thein vivobrain
- (2015) F. Wang et al. Acta Physiologica
- Cell type-specific in vivo expression of genes encoding signalling molecules in the brain in response to chronic mild stress and chronic treatment with fluoxetine
- (2015) Lu Dong et al. PSYCHOPHARMACOLOGY
- Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift
- (2015) Leif Hertz et al. Frontiers in Behavioral Neuroscience
- Inflammation, Glutamate, and Glia in Depression: A Literature Review
- (2015) Leah McNally et al. CNS SPECTRUMS
- A rapid and simple method for the determination of 3,4-dihydroxyphenylacetic acid, norepinephrine, dopamine, and serotonin in mouse brain homogenate by HPLC with fluorimetric detection
- (2014) Giuseppe Egidio De Benedetto et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Depression in Parkinson's disease
- (2014) Krystyna Ossowska et al. Pharmacological Reports
- α1-Adrenergic receptors mediate coordinated Ca2+ signaling of cortical astrocytes in awake, behaving mice
- (2013) Fengfei Ding et al. CELL CALCIUM
- Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease
- (2013) Nancy A. Pachana et al. MOVEMENT DISORDERS
- Astrogliopathology
- (2013) Alexei Verkhratsky et al. NEUROSCIENTIST
- Depression in Parkinson's disease: diagnosis and treatment
- (2012) Flavio Henrique de Rezende Costa et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Cell Type-Specific Gene Expression and Editing Responses to Chronic Fluoxetine Treatment in the In Vivo Mouse Brain and Their Relevance for Stress-Induced Anhedonia
- (2012) Baoman Li et al. NEUROCHEMICAL RESEARCH
- Contributions in astrocytes of SMIT1/2 and HMIT to myo-inositol uptake at different concentrations and pH
- (2012) Hui Fu et al. NEUROCHEMISTRY INTERNATIONAL
- 5-HT2B receptors are required for serotonin-selective antidepressant actions
- (2011) S L Diaz et al. MOLECULAR PSYCHIATRY
- Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: Implications for early intervention on disease progression
- (2011) Almas Siddiqui et al. NEUROBIOLOGY OF DISEASE
- Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse
- (2010) Lori M. Gorton et al. BEHAVIOURAL BRAIN RESEARCH
- Signaling pathways of isoproterenol-induced ERK1/2 phosphorylation in primary cultures of astrocytes are concentration-dependent
- (2010) Ting Du et al. JOURNAL OF NEUROCHEMISTRY
- Serotonin increases ERK1/2 phosphorylation in astrocytes by stimulation of 5-HT2B and 5-HT2C receptors
- (2010) Baoman Li et al. NEUROCHEMISTRY INTERNATIONAL
- 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional ‘serotonin-specific reuptake inhibitors’
- (2010) Shiquen Zhang et al. Neuron Glia Biology
- Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine
- (2010) Ronise M. Santiago et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation
- (2009) Tultul Nayyar et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Serotonin and Parkinson's disease: On movement, mood, and madness
- (2009) Susan H. Fox et al. MOVEMENT DISORDERS
- Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation
- (2009) Baoman Li et al. PSYCHOPHARMACOLOGY
- Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder
- (2009) Kevin Barley et al. SCHIZOPHRENIA RESEARCH
- Signalling pathways for transactivation by dexmedetomidine of epidermal growth factor receptors in astrocytes and its paracrine effect on neurons
- (2008) B Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol
- (2008) Gloria E. Meredith et al. PARKINSONISM & RELATED DISORDERS
- Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation
- (2008) Baoman Li et al. PSYCHOPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started